Our findings suggest that GRK5-IN-2 attenuates hepatic steatosis by suppressing triglyceride synthesis and promoting mitochondrial fatty acid oxidation, potentially through inhibition of GRK2 alongside GRK5. The gene discussed is GRK2; the disease is Hepatic steatosis.